Evidence map›Paper›PMID 23289787›Full record

ArticleJournal of medicinal food2013

West African Sorghum bicolor leaf sheaths have anti-inflammatory and immune-modulating properties in vitro.

Kathleen F Benson, Joni L Beaman, Boxin Ou, Ademola Okubena, Olajuwon Okubena, Gitte S Jensen

3 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Journal of medicinal food, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01828060 phase1 / phase2completednot on this map

Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population.

TypeinterventionalSponsorNatural Immune Systems IncRan2013Enrolled25ConditionsAnemiaArmsJobelyn™, Placebo
NCT01936064 phase1 / phase2unknown statusnot on this mapstarted 2016, after this paper: background citation

A Prospective Phase II Randomized, Blinded Study to Demonstrate the Effectiveness of Jobelyn for the Treatment of Breast Cancer Patients.

TypeinterventionalSponsorLagos State UniversityRan2016 to 2018Enrolled60ConditionsHaematological AbnormalityArmsJobelyn + Cyclophosphamide-Epirubicin6, Placebo + Cyclophosphamide - Epirubicin 6
NCT02240173 phase1 / phase2unknown statusnot on this mapstarted 2017, after this paper: background citation

Phase 2 Study of the Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia.

TypeinterventionalSponsorFederal Neuro-Psychiatric Hospital, YabaRan2017 to 2017Enrolled100ConditionsSchizophrenia and Disorders With Psychotic FeaturesArmsJobelyn, Haloperidol
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Hydrophobic Extract ofMolecules (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Effects of JobelynBasic and clinical neuroscience
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kathleen F BensonNIS Labs, Klamath Falls, OR, USA.
Joni L Beaman
Boxin Ou
Ademola Okubena
Olajuwon Okubena
Gitte S Jensen
Klamath Community College · USForêt Méditerranéenne · FRILC Dover (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of chronic inflammatory conditions on immune function is substantial, and the simultaneous application of anti-inflammatory and immune modulating modalities has potential for reducing inflammation-induced immune suppression. Sorghum-based foods, teas, beers, and extracts are used in traditional medicine, placing an importance on obtaining an increased understanding of the biological effects of sorghum. This study examined selected anti-inflammatory and immune-modulating properties in vitro of Jobelyn™, containing the polyphenol-rich leaf sheaths from a West African variant of Sorghum bicolor (SBLS). Freshly isolated primary human polymorphonuclear (PMN) and mononuclear cell subsets were used to test selected cellular functions in the absence versus presence of aqueous and ethanol extracts of SBLS. Both aqueous and nonaqueous compounds contributed to reduced reactive oxygen species formation by inflammatory PMN cells, and reduced the migration of these cells in response to the inflammatory chemoattractant leukotriene B4. Distinct effects were seen on lymphocyte and monocyte subsets in cultures of peripheral blood mononuclear cells. The aqueous extract of SBLS triggered robust upregulation of the CD69 activation marker on CD3- CD56+ natural killer (NK) cells, whereas the ethanol extract of SBLS triggered similar upregulation of CD69 on CD3+ CD56+ NKT cells, CD3+ T lymphocytes, and monocytes. This was accompanied by many-fold increases in the chemokines RANTES/CCL5, Mip-1α/CCL3, and MIP-1β/CCL4. Both aqueous and nonaqueous compounds contribute to anti-inflammatory effects, combined with multiple effects on immune cell activation status. These observations may help suggest mechanisms of action that contribute to the traditional use of sorghum-based products, beverages, and extracts for immune support.

Indexed as

Africa, WesternAntigens, CDAnti-Inflammatory AgentsCell MovementChemokine CCL3Chemokine CCL4Chemokine CCL5Chemotactic FactorsHumansImmunologic FactorsInflammationKiller Cells, NaturalLeukocytes, MononuclearLeukotriene B4MonocytesPlant ExtractsAntigens, CDAnti-Inflammatory AgentsChemokine CCL3Chemokine CCL4Chemokine CCL5Chemotactic FactorsImmunologic FactorsLeukotriene B4Plant ExtractsPolyphenolsReactive Oxygen Species

Identifiers

PMID23289787
PMCPMC3598435
OpenAlexW2081779137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.